In an in vivo study of acetic acid-induced colitis in rats, Yalniz et al. demonstrated the ability of nadroparin sodium to prevent and attenuate the expression of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB). This evidence concerns the gene NFKB1 and colitis.